Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear
The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear

Key Points

Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a Bet
Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a Bet

Nuvectis Pharma, Inc. (NVCT) closed the last trading session at $10.35, gaining 16.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Can Willdan (WLDN) Climb 38.96% to Reach the Level Wall Street Analysts Expect?
Can Willdan (WLDN) Climb 38.96% to Reach the Level Wall Street Analysts Expect?

Willdan Group (WLDN) closed the last trading session at $93.55, gaining 20% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Believe Atlassian (TEAM) Could Rally 49.75%: Here's is How to Trade
Wall Street Analysts Believe Atlassian (TEAM) Could Rally 49.75%: Here's is How to Trade

Atlassian (TEAM) closed the last trading session at $85.42, gaining 19.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts See a 30.54% Upside in Viavi Solutions (VIAV): Can the Stock Really Move This High?
Wall Street Analysts See a 30.54% Upside in Viavi Solutions (VIAV): Can the Stock Really Move This High?

Viavi Solutions (VIAV) closed the last trading session at $49.51, gaining 3.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade

Biodesix, Inc. (BDSX) closed the last trading session at $14.93, gaining 40.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Think Lifezone Metals Limited (LZM) Could Surge 69.55%: Read This Before Placing a Bet
Wall Street Analysts Think Lifezone Metals Limited (LZM) Could Surge 69.55%: Read This Before Placing a Bet

Lifezone Metals Limited (LZM) closed the last trading session at $5.09, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

How Much Upside is Left in Alliance Laundry (ALH)? Wall Street Analysts Think 26.32%
How Much Upside is Left in Alliance Laundry (ALH)? Wall Street Analysts Think 26.32%

Alliance Laundry Holdings (ALH) closed the last trading session at $24.77, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?
Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?

Carlsmed, Inc. (CARL) closed the last trading session at $12.11, gaining 18.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's  What You Should Know
Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's What You Should Know

Shares of Afya (AFYA) have gained 0.2% over the past four weeks to close the last trading session at $14, but there could still be a solid upside left in the stock if short-term price targets of

Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade
Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade

Adicet Bio, Inc. (ACET) closed the last trading session at $8.3, gaining 5.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Think Copart (CPRT) Could Surge 36.79%: Read This Before Placing a Bet
Wall Street Analysts Think Copart (CPRT) Could Surge 36.79%: Read This Before Placing a Bet

Copart, Inc. (CPRT) closed the last trading session at $33.79, gaining 2.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Believe Freshworks (FRSH) Could Rally 30.18%: Here's is How to Trade
Wall Street Analysts Believe Freshworks (FRSH) Could Rally 30.18%: Here's is How to Trade

Freshworks Inc. (FRSH) closed the last trading session at $9.08, gaining 7.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Target (TGT) is a Top-Ranked Value Stock: Should You Buy?
Target (TGT) is a Top-Ranked Value Stock: Should You Buy?

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

ARM Targets the AI Data Center Opportunity With New AGI CPU Push
ARM Targets the AI Data Center Opportunity With New AGI CPU Push

Arm Holdings ARM is accelerating its ambitions in AI infrastructure with Arm AGI CPU, a processor designed specifically for emerging agentic AI workloads. The company believes the transition from

IREN vs. CIFR: Which AI Data Center Stock Has an Edge Right Now?
IREN vs. CIFR: Which AI Data Center Stock Has an Edge Right Now?

IREN Limited IREN and Cipher Digital Inc. CIFR are key players in the artificial intelligence (AI) infrastructure market that offer next-generation data center infrastructure targeting

DAVE vs. SEZL: Which Fintech Stock Is the Better Buy Now?
DAVE vs. SEZL: Which Fintech Stock Is the Better Buy Now?

Dave DAVE and Sezzle SEZL are fintech companies that target consumer-oriented payments and provide banking alternatives. While DAVE focuses on cash advances, SEZL offers interest-free installment

Here's How CVE Targets Higher Output Through Its Broad Asset Portfolio
Here's How CVE Targets Higher Output Through Its Broad Asset Portfolio

Cenovus Energy Inc. CVE is a Canadian energy company that develops, produces, refines, and markets crude oil, natural gas and petroleum products across North America and the Asia-Pacific region

Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 145.69%: Read This Before Placing a Bet
Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 145.69%: Read This Before Placing a Bet

Shares of Q32 Bio (QTTB) have gained 6% over the past four weeks to close the last trading session at $5.8, but there could still be a solid upside left in the stock if short-term price targets of

Wall Street Analysts Think PG&E (PCG) Could Surge 37.84%: Read This Before Placing a Bet
Wall Street Analysts Think PG&E (PCG) Could Surge 37.84%: Read This Before Placing a Bet

Shares of PG&E (PCG) have gained 0.6% over the past four weeks to close the last trading session at $16.49, but there could still be a solid upside left in the stock if short-term price targets of